Validation of a Deep Learning Algorithm for Continuous, Real‐Time Detection of Atrial Fibrillation Using a Wrist‐Worn Device in an Ambulatory Environment

Author:

Poh Ming‐Zher1ORCID,Battisti Anthony J.2ORCID,Cheng Li‐Fang1ORCID,Lin Janice1ORCID,Patwardhan Anil1ORCID,Venkataraman Ganesh S.3ORCID,Athill Charles A.4ORCID,Patel Nimesh S.5ORCID,Patel Chinmay P.6ORCID,Machado Christian E.7ORCID,Ellis Jeffrey T.2ORCID,Crosson Lori A.2ORCID,Tamura Yuriko2ORCID,Plowman R. Scooter18ORCID,Turakhia Mintu P.2ORCID,Ghanbari Hamid19ORCID

Affiliation:

1. Verily Life Sciences South San Francisco CA

2. iRhythm Technologies San Francisco CA

3. Colorado Heart and Vascular Lakewood CO

4. San Diego Cardiac Center San Diego CA

5. University of Texas Southwestern Medical Center Dallas TX

6. University of Pittsburgh Medical Center Harrisburg Harrisburg PA

7. Ascension Providence Hospital Southfield MI

8. Stanford University Medical Center Palo Alto CA

9. University of Michigan Ann Arbor MI

Abstract

Background Wearable devices may be useful for identification, quantification and characterization, and management of atrial fibrillation (AF). To date, consumer wrist‐worn devices for AF detection using photoplethysmography‐based algorithms perform only periodic checks when the user is stationary and are US Food and Drug Administration cleared for prediagnostic uses without intended use for clinical decision‐making. There is an unmet need for medical‐grade diagnostic wrist‐worn devices that provide long‐term, continuous AF monitoring. Methods and Results We evaluated the performance of a wrist‐worn device with lead‐I ECG and continuous photoplethysmography (Verily Study Watch) and photoplethysmography‐based convolutional neural network for AF detection and burden estimation in a prospective multicenter study that enrolled 117 patients with paroxysmal AF. A 14‐day continuous ECG monitor (Zio XT) served as the reference device to evaluate algorithm sensitivity and specificity for detection of AF in 15‐minute intervals. A total of 91 857 intervals were contributed by 111 subjects with evaluable reference and test data (18.3 h/d median watch wear time). The watch was 96.1% sensitive (95% CI, 92.7%–98.0%) and 98.1% specific (95% CI, 97.2%–99.1%) for interval‐level AF detection. Photoplethysmography‐derived AF burden estimation was highly correlated with the reference device burden ( R 2 =0.986) with a mean difference of 0.8% (95% limits of agreement, −6.6% to 8.2%). Conclusions Continuous monitoring using a photoplethysmography‐based convolutional neural network incorporated in a wrist‐worn device has clinical‐grade performance for AF detection and burden estimation. These findings suggest that monitoring can be performed with wrist‐worn wearables for diagnosis and clinical management of AF. Registration Information URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04546763.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3